Rectum Cancer

Colorectal cancer, also known as bowel cancer, colon cancer, intestinal cancer, or rectal cancer, is the development of cancer from the colon or rectum (parts of the large intestine), characterized by the uncontrolled growth of colon cells that can invade or spread to other parts of the body. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, abdominal pain, and fatigue. Most colorectal cancers are due to lifestyle factors and genetic disorders. Risk factors include diet, obesity, smoking, and lack of physical activity. Dietary factors that increase the risk include red meat, processed meat, and alcohol. Another risk factor is inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis. Some of the inherited genetic disorders that can cause colorectal cancer include familial adenomatous polyposis and hereditary non-polyposis colon cancer; however, these represent less than 5% of cases. It typically starts as a benign tumor, often in the form of a polyp, which over time becomes cancerous. Colorectal cancer may be diagnosed by obtaining a sample of the colon during a sigmoidoscopy or colonoscopy. This is then followed by medical imaging to determine whether the cancer has spread beyond the colon or is in situ. Screening is effective for preventing and decreasing deaths from colorectal cancer. Colorectal cancer screening is recommended for average-risk adults aged 45-75, as screening effectively prevents and decreases related mortality. During colonoscopy, small polyps may be removed if found. If a large polyp or tumor is found, a biopsy may be performed to check if it is cancerous. Treatments used for colorectal cancer may include some combination of surgery, radiation therapy, chemotherapy, and targeted therapy. Cancers that are confined within the wall of the colon may be curable with surgery, while cancer that has spread widely is usually not curable, with management being directed towards improving quality of life and symptoms. The five-year survival rate in the United States is approximately 65.4% (based on data from 2016-2022) The chances of survival depend on how advanced the cancer is, whether all of the cancer can be removed with surgery, and the person's overall health. Globally, colorectal cancer is the third-most common type of cancer, making up about 10% of all cases. In 2022, there were 1.93 million new cases and 903,859 deaths from the disease. It is more common in developed countries, where more than 65% of cases are found.